| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |